In addition, a recent study revealed the relationship between the HSP60 expression level and tumor lymph node metastasis, and high levels of HSP60 have been linked to resistance to hormone therapy in prostate cancer [133]. This evidence concerns the gene HSPD1 and prostate carcinoma.